Tamborero, David
Rubio-Perez, Carlota
Deu-Pons, Jordi
Schroeder, Michael P.
Vivancos, Ana
Rovira, Ana
Tusquets, Ignasi
Albanell, Joan
Rodon, Jordi
Tabernero, Josep
de Torres, Carmen
Dienstmann, Rodrigo
Gonzalez-Perez, Abel
Lopez-Bigas, Nuria
Funding for this research was provided by:
Fundació la Marató de TV3
H2020 European Research Council (634143)
European Research Council (682398)
Ministerio de Economía y Competitividad (SAF2015-74072, BES2013-063354, RYC2013-14554)
Article History
Received: 3 November 2017
Accepted: 13 March 2018
First Online: 28 March 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: JR has consulting or advisory roles in Novartis, Eli Lilly, Orion Pharma, SERVIER, MSD, and Peptomyc and receives research funding from Bayer and Novartis. All remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.